The battle for Illumina Inc has heated up following Illumina’s rejection of a revised takeover bid from the Roche group on 2 April 2012, and a statement from Roche criticising the US company’s management. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
